140 related articles for article (PubMed ID: 11102246)
1. How hot is inflammation in acute coronary syndrome?
Verheugt FW
Eur Heart J; 2000 Dec; 21(24):1990-2. PubMed ID: 11102246
[No Abstract] [Full Text] [Related]
2. Oral platelet glycoprotein IIb/IIIa inhibition.
Newby LK; McGuire DK
Curr Cardiol Rep; 2000 Sep; 2(5):372-7. PubMed ID: 10980903
[TBL] [Abstract][Full Text] [Related]
3. Contemporary view of the acute coronary syndromes.
Moustapha A; Anderson HV
J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
[No Abstract] [Full Text] [Related]
4. Early clinical results with the new oral glycoprotein IIb/IIIa agents.
Teirstein PS
Am J Cardiol; 1999 May; 83(9A):12E-15E. PubMed ID: 10357576
[No Abstract] [Full Text] [Related]
5. Platelet glycoprotein IIb/IIIa integrin blockade: recent clinical trials in interventional cardiology.
Tcheng JE
Thromb Haemost; 1997 Jul; 78(1):205-9. PubMed ID: 9198154
[No Abstract] [Full Text] [Related]
6. Oral glycoprotein IIb/IIIa antagonists: new insights from the SYMPHONY trial.
McGuire DK; Newby LK
J Thromb Thrombolysis; 2000 Oct; 10(2):111-9. PubMed ID: 11005932
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from a clinical trial.
Armstrong PW; Newby LK; Granger CB; Lee KL; Simes RJ; Van de Werf F; White HD; Califf RM;
Circulation; 2004 Dec; 110(23):3610-4. PubMed ID: 15583090
[No Abstract] [Full Text] [Related]
8. [Use of platelet glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndrome and coronary intervention].
Kakuta T; Kishi Y; Numano F
Nihon Rinsho; 1998 Oct; 56(10):2630-4. PubMed ID: 9796330
[TBL] [Abstract][Full Text] [Related]
9. Randomisation in the SYMPHONY trial.
Altman DG
Lancet; 2000 Oct; 356(9240):1521-2. PubMed ID: 11081555
[No Abstract] [Full Text] [Related]
10. Unstable angina.
Natarajan M
Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
[No Abstract] [Full Text] [Related]
11. Low-molecular-weight heparin and other antithrombotic agents in the setting of a primarily medical treatment of unstable coronary artery disease.
Verheugt FW
Haemostasis; 2000; 30 Suppl 2():122-7; discussion 106-7. PubMed ID: 11251355
[TBL] [Abstract][Full Text] [Related]
12. Platelet glycoprotein IIb/IIIa inhibitor effect examined in 2 studies.
SoRelle R
Circulation; 2002 Jan; 105(3):E9067-8. PubMed ID: 11826859
[No Abstract] [Full Text] [Related]
13. The role of inflammation in acute coronary syndromes: review of the literature.
Elhajj II; Haydar AA; Hujairi NM; Goldsmith DJ
J Med Liban; 2004; 52(2):96-102. PubMed ID: 15884689
[TBL] [Abstract][Full Text] [Related]
14. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
Jackson G
Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
[No Abstract] [Full Text] [Related]
15. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
Van de Werf F
Thromb Haemost; 1997 Jul; 78(1):210-3. PubMed ID: 9198155
[TBL] [Abstract][Full Text] [Related]
16. Eptifibatide in acute coronary syndromes.
Segal J
N Engl J Med; 1999 Jan; 340(1):60; author reply 61. PubMed ID: 9882214
[No Abstract] [Full Text] [Related]
17. New treatment guidelines for unstable angina/non-ST-segment elevation myocardial infartion.
Howard PA
Ann Pharmacother; 2002 Nov; 36(11):1800-4. PubMed ID: 12432893
[No Abstract] [Full Text] [Related]
18. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of acute coronary syndromes.
Hughes K
Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
[TBL] [Abstract][Full Text] [Related]
20. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
